Pfizer share price corrects after FY21 results although FY22 guided to be a record year
In this article we review the Pfizer results and how the share price has reacted to the news.
Pfizer Q4 and full year results
Pfizer Q4 and FY21 results have seen the share price selling off. However, revenue and earnings growth were strong as was the groups forward guidance for FY22.
A summary of the results is as follows:
Full-Year 2021 Revenues of $81.3bn +92%
Full- Year revenues excluding contributions from Comirnaty and Paxlovid +6% to $44.4 Billion
Fourth-Quarter 2021 revenues of $23.8bn +106%
Fourth Quarter revenues excluding contributions from Comirnaty and Paxlovid -2%
Full-Year 2021 Reported Diluted Earnings Per Share (EPS) of $3.85, Adjusted Diluted EPS of $4.42
Fourth-Quarter 2021 Diluted EPS of $0.59, Adjusted Diluted EPS of $1.08
In terms of Full-Year 2022 guidance the group has said the following:
Full-Year 2022 revenues of $98.0 to $102.0bn expected
Adjusted Diluted EPS of $6.35 to $6.55 expected
Comments on results
Revenue for the fourth quarter of $23.84bn was a slight miss on consensus ($24.2bn) although Adjusted EPS of $1.08 was a beat (est. $0.87). Revenue and earnings are heavily dependent on Comirnaty and Paxlovoid, the group’s Covid vaccine and treatments. These two products account for roughly all of the group’s Q4 and FY21 revenue and earnings growth. Pfizer’s order books for these products are robust with signed commitments amounting to $54bn in sales (more than half of FY22 guided revenue). Future revenue and earnings outcomes for Pfizer will be guided by competition and necessity stemming from the pandemic. Demand is favourable for the time being although markets will be assessing demand dynamics post 2022.
Pfizer – Technical Analysis
The share price of Pfizer is correcting in the short term although the longer-term uptrend remains in place.
49.80 provides the initial support target from the correction. However, traders respecting the long-term uptrend might prefer to look for long entry on a bullish price reversal before the 49.80 support level. If this level is instead broken (with a close below), traders might look for a bullish reversal before trend line support at 45.05 for long entry. 54.25, 56.80 and 61.00 provide longer term upside targets, provided the uptrend remains intact.
This information has been prepared by IG, a trading name of IG Markets Ltd and IG Markets South Africa Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only
